Renoprotective effects of tea catechin in streptozotocin-induced diabetic rats

International Urology and Nephrology

Volumn 38, Issue 3-4, 2006, Pages 693-699

  Hase, Michiyo ^a   Babazono, Tetsuya ^a   Karibe, Sachiko ^a   Kinae, Naohide ^b   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Albuminuria; Diabetic nephropathy; Glomerular hypertrophy; Interstitial fibrosis; Tea catechins

Indexed keywords

ALBUMIN; CATECHIN; DRINKING WATER; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; INSULIN; LIPID PEROXIDE; NOVOLIN U; POLYPHENON 70S; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; GLOMERULUS; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; NONHUMAN; RAT; RAT STRAIN; RENAL PROTECTION; STREPTOZOCIN DIABETES; TEA;

ANIMALS; CATECHIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; MALE; RATS; RATS, SPRAGUE-DAWLEY; TEA;

EID: 33847353806     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-0051-0     Document Type: Article

References (21)

1. Nishikawa T, Edelstein D, Du XL, et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404:787-790
2. Terao J (1999) Dietary flavonoids as antioxidants in vivo: Conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma. J Med Invest 46:159-168
3. Schroeter H, Spencer JP, Rice-Evans C, et al (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358:547-557
4. Hasslacher C, Burklin E, Kopischke HG (1981) Inhibition of increased synthesis of glomerular basement membrane collagen in diabetic rats in vivo. Ren Physiol 4:108-111
5. Rhee SJ, Kim MJ, Kwag OG (2002) Effects of green tea catechin on prostaglandin synthesis of renal glomerular and renal dysfunction in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 11:232-236
6. Takabayashi F, Harada N, Hara Y (1995) The effects of green tea catechins (Polyphenon) on DL-ethionine-induced acute pancreatitis. Pancreas 11:127-131
7. Kinae N, Yamashita M, Esaki S, et al (1990) Inhibitory effects of tea extracts on the formation of advanced glycosylation products. The maillard reaction in food processing, human nutrition and physiology. Birkhauser Verleg, Basel, pp 221-226
8. Wallin BR, Rosengren B, Shertzer HG (1993) Lipoprotein oxidation and measurement of thibarbituric acid reacting substances formation in a single microtiter plate: Its use for evaluation of antioxidants. Anal Biochem 208:10-15
9. Kasahara Y, Ashihara Y (1981) Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 27:1922-1925
10. Weibel ER (1979) Stereological methods. Practical methods for biological morphometry, vol 1. Academic Press, London, pp 1-415
11. Fujitsuka N, Kurogi A, Hattori T, et al (1997) Effects of Onpi-to (TJ-8117) and Epicatechin-3-O -gallate on the proliferating changes in glomeruli of 5/6 nephrectomized rats. Jpn J Nephrol 39:693-700
12. Yokozawa T, Chung HY, He LQ, et al (1996) Effectiveness of green tea tannin on rats with chronic renal failure. Biosci Biotech Biochem 60:1000-1005
13. Yokozawa T, Oura H, Hattori M, et al (1993) Inhibitory effect of tannin in green tea on the proliferation of mesangial cells. Nephron 65:596-600
14. Ichikawa I, Kiyama S, Yoshioka T (1993) Renal antioxidant enzymes: Their regulation and function. Kidney Int 45:1-9
15. Christ M, Bauersachs J, Liebetrau C, et al (2002) Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation. Attenuation by the 3-Hydroxy-3-Methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51:2648-2652
16. Ceriello A, Morocutti A, Mercuri F, et al (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2177
17. Ha H, Kim KH (1995) Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 48(Suppl. 51):S18-S21
18. Kedziora-Kornatowska K, Szram S, Kornatowski T, et al (2002) The effect of verapamil on the antioxidant defence system in diabetic kidney. Clin Chim Acta 322:105-112
19. de Cavanagh EM, Inserra F, Toblli J, et al (2001) Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38:1130-1136
20. Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27:704-724
21. Brenner BM, Cooper ME, de Zeeuw D, et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med 345:861-869